Appointments at BiPar Sciences
This article was originally published in Scrip
Executive Summary
BiPar Sciences, a private US biopharmaceutical company developing PARP inhibitors as cancer therapies, has appointed Sunil Patel vice-president of corporate development and marketing, and Adrienne Weil legal counsel. Mr Patel previously served as vice-president of corporate development at Allos Therapeutics, while Ms Weil formerly worked at the law offices of Orrick, Herrington & Sutcliffe.